| abstract |
(57) [Summary] (Modified) [Structure] General formula [R 1 is of the formula: R 5 R 6 (N) m-A- {R 5 , R 6 aryl group, ar (lower) alkyl group, heterocyclic group, m is 0, 1, and A is a group represented by a lower alkylene group} or a group represented by the formula: R 5 R 6 C = A- (R 5 , R 6 and A are the same as before), and R 2 is H, lower alkyl Basis, Lower alkylidene group, R 3 and R 4 are lower alkyl groups, N The group indicated by a bold line for bonding with is a single bond or a double bond, n is 0, 1. However, an N-containing 5-membered heterocyclic compound and salts thereof, wherein n is 1 when the group shown by the bold line connecting to N is a single bond, and n is 0 when it is a double bond. [Effect] This compound is used for the prevention or treatment of dysuria such as neurogenic pollakiuria, neurogenic bladder, nocturnal enuresis, unstable bladder, bladder spasticity, chronic cystitis, chronic prostatitis and urinary incontinence. Effective for etc. |